Catalyst Wire Dossier Catalyst Wire Dossier

Beqvez

fidanacogene elaparvovec · Pfizer Europe MA EEIG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Beqvez, covering 2025-06-04 to 2025-06-04. Get the full timeline:

Most recent: EMA Withdrawn: Beqvez (previously Durveqtix) (fidanacogene elaparvovec) — Pfizer Europe MA EEIG

See pricing